Your search

In authors or contributors
  • The pervasive nature of long non-coding RNA (lncRNA) transcription in the mammalian genomes has changed our protein-centric view of genomes. But the identification of lncRNAs is an important task to discover their functional role in species. The rapid development of next-generation sequencing technology leveraged the opportunity to discover many lncRNA transcripts. However, the cost and time-consuming nature of transcriptomics verification techniques barred the research community from focusing on lncRNA identification. To overcome these challenges we developed LNCRI (Long Non-Coding RNA Identifier), a novel machine learning (ML)-based tool for the identification of lncRNA transcripts. We leveraged weighted k-mer, pseudo nucleotide composition, hexamer usage bias, Fickett score, information of open reading frame, UTR regions, and HMMER score as a feature set to develop LNCRI. LNCRI outperformed other existing models in the task of distinguishing lncRNA transcripts from protein-coding mRNA transcripts with high accuracy in human and mouse. LNCRI also outperformed the existing tools for cross-species prediction on chimpanzee, monkey, gorilla, orangutan, cow, pig, frog and zebrafish. We applied the SHAP algorithm to demonstrate the importance of most dominating features that were leveraged in the model. We believe our tool will support the research community to identify the lncRNA transcripts in a highly accurate manner. The benchmark datasets and source code are available in GitHub: http://github.com/smusleh/LNCRI. © 2013 IEEE.

  • Acute Lymphoblastic Leukemia (ALL) is a life-threatening type of cancer wherein mortality rate is unquestionably high. Early detection of ALL can reduce both the rate of fatality as well as improve the diagnosis plan for patients. In this study, we developed the ALL Detector (ALLD), which is a deep learning-based network to distinguish ALL patients from healthy individuals based on blast cell microscopic images. We evaluated multiple DL-based models and the ResNet-based model performed the best with 98% accuracy in the classification task. We also compared the performance of ALLD against state-of-the-art tools utilized for the same purpose, and ALLD outperformed them all. We believe that ALLD will support pathologists to explicitly diagnose ALL in the early stages and reduce the burden on clinical practice overall. © 2022 The authors and IOS Press.

Last update from database: 3/25/26, 6:13 PM (UTC)

Explore

Department

Resource type

Resource language